Pharmaron’s Clinical Pharmacology Center, located in Baltimore, Maryland, focuses on Phase I/IIa c
Location: United Kingdom, England, Rushden
Employees: 1001-5000
Phone: +1 240-673-0900
Total raised: $320M
Founded date: 2004
Investors 4
| Date | Name | Website |
| - | DCM Ventur... | dcm.com/ |
| - | Aisling Ca... | aislingcap... |
| - | Lake Bleu ... | lakebleu-c... |
| - | Scientia V... | scientiavc... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 11.12.2015 | - | $280M | - |
| 24.02.2011 | Series C | $40M | - |
Mentions in press and media 7
| Date | Title | Description |
| 12.09.2022 | Clinical Trials Market to Reach Value of $80.53 Billion By 2028 | Contract Research Organization to Take up over 40% market Share | Westford, USA, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Global clinical trials market continues to play a vital role in the advancement of drugs, medical devices, and therapies for patients. The number of clinical trials conducted each year has b... |
| 10.01.2022 | Pharmaron acquires commercial API manufacturing facility in the United Kingdom from Recipharm | Pharmaron acquires commercial API manufacturing facility in the United Kingdom from Recipharm Mon, Jan 10, 2022 12:05 CET Continues to strengthen the global chemistry and manufacturing capabilities and capacities Pharmaron Beijing Co., Limi... |
| 21.09.2020 | PHARMARON BEIJING CO., LTD. Pharmaron Beijing : 2020 INTERIM REPORT | Pharmaron Beijing Co., Ltd.* (a joint stock company incorporated in the People's Republic of China with limited liability) Stock Code: 3759 2020 INTERIM REPORT For identification purposes only Premier R&D service provider for the life s... |
| 20.12.2019 | Imagined futures: Baltimore tech and biz leaders tell us what they envision for the next decade | The year is winding down, which offers time to pause and look back at how we were moving, reading, hiring and exiting in 2019. But in this case, it’s not just about one year: The coming calendar turnover marks the end of the decade, and the... |
| 11.12.2015 | Pharmaron Receives US$280M Investment | Pharmaron, a Beijing, China-based contract research organization (CRO), received an over US$280m investment. The consortium was led by CITIC M&A Fund and Legend Capital. The company intends to use the funds to further strengthen its cor... |
| 03.03.2011 | Pharmaron Finds $40M | Irvine-based Pharmaron, a provider of R&D services to the pharmaceutical and biotech industry, said last week that it has raised $40M in a Series C funding round. The round came from DCM, Legend Capital, GL Capital Group, and others. Th... |
| 24.02.2011 | Pharmaron Holding Closes $40m Series C Financing | Pharmaron Holding Limited, a Beijing, China, and Irvine, CA, USA-based provider of R&D services to small and large pharmaceutical and biotech companies from around the world, has closed an over $40m Series C financing round. Investors i... |